基于人工智能的临床决策支持系统在肝细胞癌中的应用  

Application of Clinical Decision Support Sys-tem Based on Artificial Intelligence in Hepatocellular Carcinoma

作　　者：汪笑楠 王海久[2] 

机构地区：[1]青海大学临床医学院,青海 西宁 [2]青海大学附属医院普通外科学二科,青海 西宁

出　　处：《临床医学进展》2023年第7期11368-11374,共7页Advances in Clinical Medicine

摘　　要：肝癌是世界范围内一种较为常见的恶性肿瘤,随着科技的飞速发展,目前在肝癌的早期诊断和治疗方面,基于人工智能的临床决策支持系统提供了新的解决方案。它能实时收集临床数据和医学知识,提供更准确的诊断和治疗建议。本文对近年来基于人工智能的临床决策系统进行了综述,包括肝癌的预测、诊断、个性化诊疗方案和预后监测等方面。同时,也讨论了该领域面临的挑战和未来的发展方向,总的来说,基于人工智能的临床决策支持系统对肝癌的早期诊断和治疗具有重要的应用价值。Liver cancer is a relatively common malignant tumor worldwide. With the rapid development of technology, artificial intelligence-based clinical decision support systems now provide new solutions in the early diagnosis and treatment of liver cancer. It can collect clinical data and medical knowledge in real time to provide more accurate diagnosis and treatment recommendations. This paper provides an overview of AI-based clinical decision systems in recent years, including the pre-diction, diagnosis, personalized treatment plan and prognosis monitoring of liver cancer. The chal-lenges and future directions in this field are also discussed. In general, AI-based clinical decision support systems have important application value for early diagnosis and treatment of liver cancer.

关 键 词：人工智能(AI) 临床决策支持系统(CDSS) 肝细胞癌(HCC) 

分 类 号：R73[医药卫生—肿瘤]